Analysts expect over 2021 decreasing revenue Biogen

Tomorrow the American Biogen will report its past quarters results. Over the current book year the total revenu from the company based in Cambridge will be 9.88 billion USD (consensus estimates). This is hugely lower than 2021's revenue of 10.98 billion USD.

Historical revenues and results Biogen plus estimates 2021

The analysts expect for 2021 a net profit of 2.23 billion USD. For this year most of the analysts expect a profit per share of 15.42 USD. With this the price/earnings-ratio is 13.78.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a relatively high 2.64 percent.

Biogen 's market capitalization is based on the number of outstanding shares around 32.39 billion USD. -21

Historical stock prices Biogen

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.